To direct the Secretary of Health and Human Services to carry out a public awareness campaign to increase participation by women in clinical trials that are conducted or supported by the National Institutes of Health, and for other purposes.

# HR 7694 Summary **What the Bill Would Do** HR 7694 would require the Secretary of Health and Human Services to launch a public awareness campaign aimed at encouraging more women to participate in clinical trials funded or conducted by the National Institutes of Health (NIH). The campaign would work to increase female representation in medical research studies, addressing a long-standing gap in how medical treatments are tested and validated. **Who It Affects and Why It Matters** This bill affects women interested in medical research, patients seeking new treatments, and the medical research community. Historically, women have been underrepresented in clinical trials, which can result in medications and treatments that are less studied in female populations.

A targeted awareness campaign could help researchers better understand how drugs and therapies work differently across genders, potentially improving healthcare outcomes for everyone. **Current Status** HR 7694 is currently in committee and has not yet been voted on by the full House. It was introduced by Representative Josh Gottheimer (D-NJ) in the 119th Congress. The bill would require the government to spend resources on outreach but does not mandate participation—it focuses on making information about trial opportunities more accessible to women.